Rapid preparation of 1-vinylimidazole based non-affinity polymers for the highly-selective purification of antibodies from multiple biological sources.


Journal

Journal of chromatography. A
ISSN: 1873-3778
Titre abrégé: J Chromatogr A
Pays: Netherlands
ID NLM: 9318488

Informations de publication

Date de publication:
22 Nov 2020
Historique:
received: 12 08 2020
revised: 02 10 2020
accepted: 04 10 2020
pubmed: 21 10 2020
medline: 2 12 2020
entrez: 20 10 2020
Statut: ppublish

Résumé

There is an urgent need for developing advanced purification techniques with the merits of low cost and satisfactory capacity in order to meet the challenges in the current downstream purification of monoclonal antibodies (mAbs). Herein, a simple and inexpensive nitrogen heterocycle molecule, 1-vinylimidazole (VIM), was proposed as the capture ligand of antibodies for the first time. The corresponding VIM-based non-affinity polymeric material (polyVIM) was then fabricated via a one-step polymerization for use in the highly selective purification of antibodies. Compared to the previously reported materials, this novel material exhibited many advantages without clearly sacrificing selectivity, such as a simpler and faster fabrication (within 1.5 h), comparable or even higher binding capacity (saturated static adsorption capacity > 190 mg/g polymer, dynamic binding capacity about 31.62 mg/g polymer), lower non-specific protein adsorption, and much lower cost. Notably, the polyVIM can effectively purify the antibodies from multiple biological sources with high purity (95.4% for mAbs in the cell culture medium, 93.3% for hIgG in the human serum), with an acceptable recovery (91.6% for mAbs, 77.0% for hIgG), and good reusability (> 10 times). Moreover, the target ELISA binding assay and NFAT-luc reporter gene assay demonstrated that the enriched antibodies can well maintain their binding activity and bioactivity during the whole purification process. The excellent performance of the polyVIM material may be attributed to the high recognition ability of VIM for antibodies, as well as the biocompatible and antifouling properties of the porous polymer. This study provides a promising alternative material for the purification of mAbs in downstream processes and the enrichment of hIgG in human serum.

Identifiants

pubmed: 33080535
pii: S0021-9673(20)30881-5
doi: 10.1016/j.chroma.2020.461607
pii:
doi:

Substances chimiques

Antibodies, Monoclonal 0
Imidazoles 0
Immunoglobulin G 0
Ligands 0
Polymers 0
Bevacizumab 2S9ZZM9Q9V
N-vinylimidazole ODY9ION63A

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

461607

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Yutian Lei (Y)

Institute of Pharmaceutical Analysis, College of Pharmacy, Jinan University, Guangzhou 510632, China.

Xiao Liu (X)

Institute of Pharmaceutical Analysis, College of Pharmacy, Jinan University, Guangzhou 510632, China.

Li Lu (L)

Institute of Pharmaceutical Analysis, College of Pharmacy, Jinan University, Guangzhou 510632, China.

Cuihua Liu (C)

Bio-Thera Solutions, Ltd., Guangzhou 510700, China.

Rongrong Xu (R)

Institute of Pharmaceutical Analysis, College of Pharmacy, Jinan University, Guangzhou 510632, China.

Shengfeng Huang (S)

Institute of Pharmaceutical Analysis, College of Pharmacy, Jinan University, Guangzhou 510632, China.

Yuan Shen (Y)

Institute of Pharmaceutical Analysis, College of Pharmacy, Jinan University, Guangzhou 510632, China.

Chunping Deng (C)

Bio-Thera Solutions, Ltd., Guangzhou 510700, China.

Jinchen Yu (J)

Bio-Thera Solutions, Ltd., Guangzhou 510700, China.

Tingting Zhang (T)

Institute of Pharmaceutical Analysis, College of Pharmacy, Jinan University, Guangzhou 510632, China.

Jacques Crommen (J)

Institute of Pharmaceutical Analysis, College of Pharmacy, Jinan University, Guangzhou 510632, China; Laboratory of Analytical Pharmaceutical Chemistry, Department of Pharmaceutical Sciences, CIRM, University of Liege, CHU B36, B-4000, Liege, Belgium.

Qiqin Wang (Q)

Institute of Pharmaceutical Analysis, College of Pharmacy, Jinan University, Guangzhou 510632, China; Department of Pharmacy and Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine & New Drug Research, Jinan University, Guangzhou 510632, China. Electronic address: qiqinxtu@163.com.

Zhengjin Jiang (Z)

Institute of Pharmaceutical Analysis, College of Pharmacy, Jinan University, Guangzhou 510632, China; Department of Pharmacy and Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine & New Drug Research, Jinan University, Guangzhou 510632, China. Electronic address: jzjjackson@hotmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH